Showing 1 - 20 results of 75 for search 'Gerd Pluschke', query time: 0.09s
Refine Results
-
1
-
2
Differential gene repertoire in Mycobacterium ulcerans identifies candidate genes for patho-adaptation. by Michael Käser, Gerd Pluschke
Published 2008-01-01
Article -
3
Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease by Louisa Warryn, Gerd Pluschke
Published 2023-09-01
Article -
4
Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates. by Angèle Bénard, Claudia Sala, Gerd Pluschke
Published 2016-01-01
Article -
5
Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease. by Miriam Bolz, Sarah Kerber, Gert Zimmer, Gerd Pluschke
Published 2015-01-01
Article -
6
Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b by Lukas Muri, Lukas Muri, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke, Gerd Pluschke, Emma Ispasanie, Emma Ispasanie
Published 2022-12-01
Article -
7
Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals by Emma Ispasanie, Emma Ispasanie, Lukas Muri, Lukas Muri, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke, Gerd Pluschke
Published 2021-10-01
Article -
8
Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals by Lukas Muri, Lukas Muri, Emma Ispasanie, Emma Ispasanie, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke, Gerd Pluschke
Published 2021-10-01
Article -
9
-
10
Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment. by Nicole Scherr, Gerd Pluschke, Charles J Thompson, Santiago Ramón-García
Published 2015-08-01
Article -
11
-
12
-
13
In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway by Emma Ispasanie, Emma Ispasanie, Lukas Muri, Lukas Muri, Marc Schmid, Marc Schmid, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke, Gerd Pluschke
Published 2023-06-01
Article -
14
-
15
-
16
-
17
Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009 [v1; ref status: indexed, http://f1000r.es/37h] by Emma Ispasanie, Gerd Pluschke, Abraham Hodgson, Ali Sie, Calman MacLennan, Oliver Koeberling
Published 2014-11-01
Article -
18
-
19
-
20